Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
about
Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and managementMeasuring the value of public health systems: the disconnect between health economists and public health practitionersInborn errors of metabolism identified via newborn screening: Ten-year incidence data and costs of nutritional interventions for research agenda planningSpecific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screeningNewborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis.Healthcare professionals' and parents' experiences of the confirmatory testing period: a qualitative study of the UK expanded newborn screening pilot.Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France.Congenital Hypothyroidism Long-Term Follow-up Project: Navigating the Rough Waters of a Multi-Center, Multi-State Public Health Project.An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.Economic analyses of human genetics services: a systematic review.What role for public health in genetics and vice versa?The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update.The Role of Information Provision in Economic Evaluations of Newborn Bloodspot Screening: A Systematic ReviewPolicy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.Newborn screening in Canada - Are we out of step?Impact of false-positive newborn metabolic screening results on early health care utilization.QALY weights for neurosensory impairments in pediatric economic evaluations: case studies and a critique.Biomarkers in pediatrics: children as biomarker orphans.Bridging evidence and consensus methodology for inherited metabolic disorders: creating nutrition guidelines.Inborn errors of metabolism and expanded newborn screening: review and update.Is gene discovery research or diagnosis?Cost-benefit analysis: newborn screening for inborn errors of metabolism in Lebanon.Universal screening for extracardiac abnormalities in neonates with congenital heart disease.Early vs. delayed diagnosis of severe combined immunodeficiency: a family perspective survey.Expanded newborn screening: Lessons learned from MCAD deficiency.Reduction in newborn screening metabolic false-positive results following a new collection protocol.Multimode smartphone biosensing: the transmission, reflection, and intensity spectral (TRI)-analyzer.Cost-benefit analysis of hyperphenylalaninemia due to 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency: for consideration of expanded newborn screening in Hong Kong.
P2860
Q24616340-AFACBC9B-D756-4A2E-9686-34D4EE46A4A7Q24657827-99022AA0-6E09-4E0A-BDA7-327CF2D5D5A9Q30840211-2AF80685-8A3C-49F1-9F9B-1224BD7B9E1DQ31088945-0FC29A6A-EEBA-47E1-8D07-4FA6E181DAB1Q33589004-D09F76F2-2310-4841-9455-6E33DFECA875Q33651744-C059C44E-A7B8-4F18-9208-7F9A58F6C9FCQ34297808-BBC11C1F-6EAA-4F29-8B41-3CBAB7E86270Q35616749-776D4FC1-1D07-4118-B578-6B14FC449C5BQ35741264-796F9971-C979-4DBE-8641-65E1C60EA3F6Q36296074-F552D7F9-370F-4737-ACDE-5A88EE5622CCQ36402152-250367FB-A97C-44E2-8368-65AF4A8CA94AQ36450404-FFB5CDCE-1AD5-41A6-8958-049AA615A40DQ36573343-B95DD138-FFF0-406C-8B10-C506155E4DC6Q37052030-48E94AF5-2BA6-4601-B129-966BE197EF59Q37293873-CE6B2597-C62E-4B8F-B696-E0A02BC63C21Q37411500-DBB6C810-68BD-46BF-AC42-556B770338FBQ37764874-5F1D030D-88DE-453F-B122-D856E0B05EC1Q37817271-E3E1FB93-2A7E-4200-8A17-3A8A146BF406Q37968348-36282420-C381-46A2-BDA3-81CE1A82AE38Q38167824-054E6B1D-0B2A-4D00-A726-2DECB46F2DF1Q38442473-72E82D36-22FB-41C7-B5C2-DC35CEAD8FEDQ40848613-E317608B-2CD1-48EA-A58C-DC1E2270C5FBQ42100695-ECA22875-07AA-452A-8D6E-4F81713AEE96Q42573665-94C2107F-6571-4503-8794-3CDB74AD82FFQ43079401-ABF7A92A-A54E-42A6-A091-788E9627E202Q44665599-65ABE349-3AA5-40F6-879A-1744EF2995C3Q48017636-C35D3BB4-60D7-4E9B-A729-2FE8CE5502A6Q51246313-61ACE854-A92A-4F39-B9E5-85DFDD4BB970
P2860
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
@ast
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
@en
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
@nl
type
label
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
@ast
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
@en
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
@nl
prefLabel
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
@ast
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
@en
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
@nl
P2093
P356
P1433
P1476
Cost-benefit analysis of universal tandem mass spectrometry for newborn screening.
@en
P2093
Christopher J Colby
Edgar J Schoen
John C Baker
Trinh T To
P304
P356
10.1542/PEDS.110.4.781
P407
P577
2002-10-01T00:00:00Z